MedTrace Logo

Role of the Stress in the Development of the Metabolic Syndrome

NCT01538082 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 738

Last updated 2012-02-23

No results posted yet for this study

Summary

The purpose of this study is determine the incidence of metabolic syndrome (MetS) in people of high risk, of 40 or more years and attended in the Primary Care. Evaluating the association between anxiety, depression, quality of life and the vital stressful events, and the development of the metabolic syndrome in general population.

Our hypothesis is that population of the cohort with bigger degree of stress will develop earlier the metabolic syndrome.

If our hypothesis about the metabolic syndrome are demonstrated, it would allow establishing in a future interventions on these factors of risk to prevent or to decrease the incidence of this syndrome in the Primary Care.

Conditions

  • Anxiety Disorders
  • Depressive Disorders
  • Metabolic Syndrome
  • Stress Disorders

Sponsors & Collaborators

  • Catalan Society of Family Medicine

    collaborator OTHER

  • Spanish Society of Family and Community Medicine

    collaborator OTHER

  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    lead OTHER

Principal Investigators

  • Yolanda Ortega, MD · Catalan Institute of Health

  • Juan J Cabré, MD, PhD · Catalan Institute of Health

  • Josep L Piñol, MD, PhD · Catalan Institute of Health

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538082 on ClinicalTrials.gov